AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Zainab M Aldarraji

Examiner Zainab M Aldarraji appears to be about average relative to their peer examiners. Their lifetime grant ratio is 46.8%, they average 2.60 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.60
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
6 years (2021-2026)
Phone
(571) 272-8726
Predicted Supervisor
Carey Michael
Supervisor Phone
(571) 270-7235
Tech Center
3700 - Mechanical Engineering, Manufacturing and Products
Group
3790 - Medical Instruments, Diagnostic Equipment, and Treatment Devices

Metrics

Applications Evaluated
154
Granted Applications
72
Non-Granted Applications
82
Avg OA / Grant
2.60
Last OA Observed
March 2026 (2 months ago)
Art Units Seen
3793 , 3797
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 46.8% 2.60
Art Unit 17 41.4% 2.18
Group 327 40.3% 2.25
Tech Center 2,632 49.9% 2.01
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2021; examiner may not yet have been active in the available dataset.
2021 14 8 57.1%
2022 28 15 53.6%
2023 29 18 62.1%
2024 22 17 77.3%
2025 49 14 28.6%
2026 12 0 0.0%

72 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 160 0.6% 8.1% 85.6% 3.1%
2 108 0.0% 6.5% 91.7% 1.9%
3 73 0.0% 2.7% 95.9% 1.4%
4 51 0.0% 0.0% 96.1% 3.9%
5 31 3.2% 3.2% 93.5% 0.0%
6 18 0.0% 0.0% 94.4% 5.6%
7 9 0.0% 0.0% 100.0% 0.0%
8 4 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2020
0.0%
2021
0.0%
2022
0.0%
2023
0.0%
2024
1.3%
2025
8.3%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.